Australian Government Department of Health Review of the Life Saving Drugs Program medicines: Mucopolysaccharidosis Type II (MPS II) Final Review Protocol
- Stathis, S. (Advisor)
- Lisa R. Fodero (Advisor)
- Nerissa Soh (Advisor)
- Rob Zebara (Advisor)
- Justine Biggs (Advisor)
- Michael Ortiz (Advisor)
Activity: End user engagement and expertise › Advisory position